NO20025264L - Reduktiv alkyleringsprosess - Google Patents

Reduktiv alkyleringsprosess

Info

Publication number
NO20025264L
NO20025264L NO20025264A NO20025264A NO20025264L NO 20025264 L NO20025264 L NO 20025264L NO 20025264 A NO20025264 A NO 20025264A NO 20025264 A NO20025264 A NO 20025264A NO 20025264 L NO20025264 L NO 20025264L
Authority
NO
Norway
Prior art keywords
reductive alkylation
alkylation process
saccharide
amines
provides
Prior art date
Application number
NO20025264A
Other languages
English (en)
Other versions
NO330134B1 (no
NO20025264D0 (no
Inventor
Martin S Linsell
Original Assignee
Theravance Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Theravance Inc filed Critical Theravance Inc
Publication of NO20025264D0 publication Critical patent/NO20025264D0/no
Publication of NO20025264L publication Critical patent/NO20025264L/no
Publication of NO330134B1 publication Critical patent/NO330134B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Nanotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20025264A 2000-05-02 2002-11-01 Fremgangsmåte for alkylering av et glykopeptid NO330134B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20117800P 2000-05-02 2000-05-02
US21314800P 2000-06-22 2000-06-22
PCT/US2001/014017 WO2001083521A2 (en) 2000-05-02 2001-05-01 Reductive alkylation process on glycopeptides

Publications (3)

Publication Number Publication Date
NO20025264D0 NO20025264D0 (no) 2002-11-01
NO20025264L true NO20025264L (no) 2002-12-18
NO330134B1 NO330134B1 (no) 2011-02-21

Family

ID=26896472

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025264A NO330134B1 (no) 2000-05-02 2002-11-01 Fremgangsmåte for alkylering av et glykopeptid

Country Status (13)

Country Link
US (1) US6831150B2 (no)
EP (1) EP1276759B1 (no)
JP (2) JP4713810B2 (no)
KR (1) KR100856479B1 (no)
CN (1) CN100532392C (no)
AT (1) ATE402951T1 (no)
AU (1) AU2001257464A1 (no)
CA (1) CA2407994C (no)
DE (1) DE60135102D1 (no)
ES (1) ES2311014T3 (no)
NO (1) NO330134B1 (no)
SI (1) SI1276759T1 (no)
WO (1) WO2001083521A2 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI312785B (en) * 2001-08-24 2009-08-01 Theravance Inc Process for preparing vancomycin derivatives
TWI275594B (en) * 2001-08-24 2007-03-11 Theravance Inc Process for preparing vancomycin phosphonate derivatives
EP2753638A1 (en) 2011-09-09 2014-07-16 Sandoz AG Process for the synthesis of telavancin and its pharmaceutically acceptable salts as well as n-protected derivatives thereof
EP2753637A1 (en) 2011-09-09 2014-07-16 Sandoz AG Process for the synthesis of telavancin, its pharmaceutically acceptable salts as well as an n-protected imine-derivative of telavancin
CN103897040B (zh) * 2012-12-27 2018-05-22 浙江医药股份有限公司新昌制药厂 新型糖肽类化合物或其药用盐及其制备方法、以及药物组合物和用途
CN106188243B (zh) * 2015-05-05 2020-06-26 博瑞生物医药（苏州）股份有限公司 一种奥利万星的制备方法
KR20190005940A (ko) 2016-05-09 2019-01-16 셀리아 파마슈티칼즈 에이피에스 안정화된 글리코펩티드 항생제 제형
CN108409837B (zh) 2018-03-06 2021-09-24 上海来益生物药物研究开发中心有限责任公司 一组具有抗耐药性细菌活性的糖肽类化合物、其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL78597A0 (en) 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
US4698327A (en) * 1985-04-25 1987-10-06 Eli Lilly And Company Novel glycopeptide derivatives
US4644533A (en) * 1985-05-06 1987-02-17 American Telephone & Telegraph Company Packet switch trunk circuit queueing arrangement
US4643987A (en) * 1985-08-14 1987-02-17 Eli Lilly And Company Modified glycopeptides
ZA909847B (en) * 1989-12-13 1992-08-26 Lilly Co Eli Glycopeptide derivatives
US5750509A (en) * 1991-07-29 1998-05-12 Gruppo Lepetit S.P.A. Amide derivatives of antibiotic A 40926
PE40996A1 (es) * 1994-01-28 1996-10-14 Lilly Co Eli Derivado de antibiotico de glucopeptido
US5840684A (en) * 1994-01-28 1998-11-24 Eli Lilly And Company Glycopeptide antibiotic derivatives
US5919756A (en) 1996-06-28 1999-07-06 Eli Lilly And Company Amides
US5952466A (en) * 1997-11-12 1999-09-14 Eli Lilly And Company Reductive alkylation of glycopeptide antibiotics
US5939382A (en) 1996-11-21 1999-08-17 Eli Lilly And Company Reducing agent for reductive alkylation of glycopeptide antibiotics
ID18900A (id) * 1996-11-21 1998-05-20 Lilly Co Eli Alkilasi menurun dari gliko peptida anti biotik
US5916873A (en) * 1997-04-17 1999-06-29 Eli Lilly And Company Teicoplanin derivatives
EP1060189A1 (en) 1998-02-20 2000-12-20 Advanced Medicine, Inc. Derivatives of glycopeptide antibacterial agents
ES2201825T3 (es) 1998-12-23 2004-03-16 Theravance, Inc. Derivados del glicopeptidos y composiciones farmaceuticas que los contienen.
CA2370782A1 (en) 1999-04-02 2000-10-12 The Trustees Of Princeton University Desleucyl glycopeptide antibiotics and methods of making same
AU2001259303A1 (en) * 2000-06-22 2002-01-02 Advanced Medicine, Inc. Glycopeptide carboxy-saccharide derivatives

Also Published As

Publication number Publication date
KR100856479B1 (ko) 2008-09-04
DE60135102D1 (de) 2008-09-11
US20020010131A1 (en) 2002-01-24
SI1276759T1 (sl) 2008-12-31
ES2311014T3 (es) 2009-02-01
NO330134B1 (no) 2011-02-21
JP4713810B2 (ja) 2011-06-29
ATE402951T1 (de) 2008-08-15
WO2001083521A2 (en) 2001-11-08
CA2407994A1 (en) 2001-11-08
EP1276759B1 (en) 2008-07-30
CN1432023A (zh) 2003-07-23
US6831150B2 (en) 2004-12-14
JP2008222718A (ja) 2008-09-25
WO2001083521A3 (en) 2002-09-19
JP2003531917A (ja) 2003-10-28
CA2407994C (en) 2010-02-02
NO20025264D0 (no) 2002-11-01
CN100532392C (zh) 2009-08-26
AU2001257464A1 (en) 2001-11-12
EP1276759A2 (en) 2003-01-22
KR20020093110A (ko) 2002-12-12

Similar Documents

Publication Publication Date Title
DE60105899D1 (de) Schaltvorrichtung, insbesondere zum optischen schalten
IL176328A0 (en) Method for purifying fsh
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
DE60135851D1 (de) Plasmaquelle für die spektrometrie
ATE472583T1 (de) Verflüssiger für invert-emulsionen
JO2242B1 (en) Phosphatase inhibitors
PT1456154E (pt) Processo para a alquilação do benzeno
NO20025264L (no) Reduktiv alkyleringsprosess
DE60225061D1 (de) Fräsblechabstandsverstellung für doppelnadelbarrige raschelmaschinen
DE60202512D1 (de) Vorrichtung für Elektrodeionisation
DE50104705D1 (de) Kolbenring für kolben-maschinen
BR0208938B1 (pt) método de pré-tratamento para material de deposição não eletrolìtica.
DE60139812D1 (de) Zuführvorrichtung für artikel
DK1392722T3 (da) Fremgangsmåde vedrörende echinocandiner
HK1059760A1 (en) Fixing device.
NO20033921L (no) Inhibitor av monoaminopptak
BR0108268A (pt) N-acilação seletiva de análogos de glicopeptìdeo a82846
FR2821128B1 (fr) Distributeur pneumatique
GB2377496B (en) Multi-frequency seismic source
AR027751A1 (es) Proceso para la n-formilacion selectiva de n-hidroxilaminas
DE50007879D1 (de) Spannzylinder für Spanneinrichtungen
DK1192308T3 (da) Fremgangsmåde til fremstilling af elastiske bånd til beklædningsindustrien
UY26642A1 (es) Proceso para la n-formulación selectiva de n-hidroxilaminas
FI20012492A0 (fi) Hylkyjärjestelmä paperikonetta tai vastaavaa varten
WO2001074792A3 (en) Process for the preparation of matrix metalloproteinase inhibitors

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA R&D IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAVANCE BIOPHARMA ANTIBIOTICS IP, US

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: CUMBERLAND PHARMACEUTICALS INC., US

MK1K Patent expired